Marvin L White

CIK 1493324 · President and CEO · last filed 2026-05-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$947.2K

Companies

4

Total Filings

56

Lifetime Open-Market Net

-$587.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EBS Director 113,839 $8.32 $947.1K -$1.34M 17 2026-05-04
APVO President and CEO 12 $4.78 $57 $685.9K 29 2025-08-08
CoLucid Pharmaceuticals, Inc. (CLCD) Delisted Director $0 6 2017-03-01
WASHINGTON PRIME GROUP INC. (WPG) Delisted Director 5,000 $0.83 $4.2K $71.2K 4 2016-05-19

Recent Filings · Page 2 of 6

56 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-05-30 EBS Grant (A) +33,847 $0 EDGAR
2023-03-07 APVO Mixed +9,582 $0 EDGAR
2023-01-30 APVO Exer (M) +4,791 $0 EDGAR
2022-06-07 APVO Grant (A) $0 EDGAR
2022-05-31 EBS Grant (A) +8,446 $0 EDGAR
2022-03-04 APVO Grant (A) $0 EDGAR
2022-02-01 APVO Exer (M) +4,792 $0 EDGAR
2021-05-24 EBS Grant (A) +5,027 $0 EDGAR
2021-02-17 APVO Grant (A) $0 EDGAR
2020-10-05 EBS Grant (A) +3,629 $0 EDGAR
Showing 1120 of 56
Page 2 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.